SEC Filing Analysis: QUAKER CHEMICAL CORP (KWR)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A Vice President at Quaker Chemical received a routine grant of 61 Restricted Stock Units (RSUs) as part of their compensation package.
• Market Impact: Negligible. This is a non-market transaction with no immediate impact on stock price or trading volume.

Company Information

Field	Value
Company	QUAKER CHEMICAL CORP
Ticker Symbol	KWR
CIK	0000081362
Industry	Miscellaneous Products of Petroleum & Coal

Insider Information

Field	Value
Name	Frodl Andre
CIK	0002089257
Title/Position	VP, R&D-Metals & Metalworking
Relationship	Officer

Transaction Details

Field	Value
Form Type	4
Transaction Date	2025-10-15
Transaction Code	A (Grant)
Security Type	Restricted Stock Units
Shares Involved	61
Price Per Share	$0.00
Total Value	$0
Shares Owned After	61
Ownership Type	Direct

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$0
% of Market Cap	0.0%
Shares Transacted	61
% of Shares Outstanding	0.00035%
Post-Transaction Ownership	61 shares (0.00035% of outstanding)
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: The transaction value is $0, making it immaterial against the company's $2.30 billion market capitalization.
• Ownership Concentration: The insider's post-transaction ownership is negligible at 0.00035% of total shares outstanding.
• Dilution Impact: The grant of 61 shares represents a potential dilution of only 0.00035%, which is insignificant for existing shareholders.
• Transaction Significance: This is a standard equity award for an officer, not an open-market purchase or sale. Its significance is low and primarily relates to executive compensation rather than market sentiment.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: Equity grants are a common form of compensation and are not indicative of an insider's immediate market outlook. The market does not typically react to small, routine RSU awards.

Volume & Sentiment

• Expected Volume Impact: None. This is not an open-market transaction and will not affect trading volume.
• Sentiment Indicator: Neutral. The filing is a routine disclosure of executive compensation.

Investment Insights

Positive Market Indicators

• Equity awards can serve as a tool to align executive interests with those of shareholders and aid in talent retention.

Risk Factors

• There are no discernible risks associated with this specific transaction.

Key Takeaways

1. Routine Compensation: This Form 4 filing details a standard grant of RSUs to a company VP.
2. No Market Signal: The transaction is not an open-market buy or sell and therefore provides no insight into the insider's sentiment on the stock's current valuation.
3. Negligible Dilution: The number of shares granted is extremely small relative to the total shares outstanding, resulting in no meaningful dilution for investors.

Additional Context

Transaction Notes

• Vesting Schedule: Per the filing's footnotes, the RSUs vest in three annual installments beginning on March 15, 2026. This long-term vesting schedule is designed to retain the executive.
• Security Type: These are Restricted Stock Units, which represent a contingent right to receive shares in the future, not immediate ownership of common stock.